Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma

Current treatments for cholangiocarcinoma (CCA) are largely unsuccessful due to late diagnosis at advanced stage, leading to high mortality rate. Consequently, improved therapeutic approaches are urgently needed. Chimeric antigen receptor (CAR) T cell therapy is a newly potential therapy that can re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Supimon, Kamonlapat, Sangsuwannukul, Thanich, Sujjitjoon, Jatuporn, Phanthaphol, Nattaporn, Chieochansin, Thaweesak, Poungvarin, Naravat, Wongkham, Sopit, Junking, Mutita, Yenchitsomanus, Pa-thai
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973425/
https://ncbi.nlm.nih.gov/pubmed/33737613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85747-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados